Clinical Concerns and the Validity of Clinical Trials

C. Lidz, C. Benedicto, Karen Albert, P. Appelbaum, L. Dunn
{"title":"Clinical Concerns and the Validity of Clinical Trials","authors":"C. Lidz, C. Benedicto, Karen Albert, P. Appelbaum, L. Dunn","doi":"10.1080/21507716.2013.770105","DOIUrl":null,"url":null,"abstract":"Background: The validity of results from clinical trials depends on both clinical researchers and participants consistently and strictly following research protocols. However, clinical trial researchers are also expected to provide excellent medical care to the participants. These two commitments may conflict under some circumstances. Methods: A questionnaire previously used for a national Internet-based survey was adapted to conduct in-depth, semistructured interviews in order to further explore reported attitudes and/or behaviors that indicated that patient well-being sometimes took precedence over strict adherence to the study protocol. We conducted 96 interviews with researchers working on Phase II and/or Phase III clinical trials in a variety of medical fields at four major academic medical centers. Results: Due to concerns for the welfare of their patients, the researchers we interviewed described decisions that involved “individualized” rather than protocol-driven decisions about recruitment, protocol implementation, and termination. The individualized decisions could threaten the validity of the trials. Conclusions: Clinical researchers should be strongly encouraged to carefully document and report selective recruitment, implementation, and termination decisions so that it will be easier to evaluate to whom the results of research studies apply. Those who design clinical trials should be careful to construct them so that the clinicians who carry them out will not feel that implementing the protocol will violate their commitments to good clinical care.","PeriodicalId":89316,"journal":{"name":"AJOB primary research","volume":"36 1","pages":"26 - 38"},"PeriodicalIF":0.0000,"publicationDate":"2013-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJOB primary research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21507716.2013.770105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: The validity of results from clinical trials depends on both clinical researchers and participants consistently and strictly following research protocols. However, clinical trial researchers are also expected to provide excellent medical care to the participants. These two commitments may conflict under some circumstances. Methods: A questionnaire previously used for a national Internet-based survey was adapted to conduct in-depth, semistructured interviews in order to further explore reported attitudes and/or behaviors that indicated that patient well-being sometimes took precedence over strict adherence to the study protocol. We conducted 96 interviews with researchers working on Phase II and/or Phase III clinical trials in a variety of medical fields at four major academic medical centers. Results: Due to concerns for the welfare of their patients, the researchers we interviewed described decisions that involved “individualized” rather than protocol-driven decisions about recruitment, protocol implementation, and termination. The individualized decisions could threaten the validity of the trials. Conclusions: Clinical researchers should be strongly encouraged to carefully document and report selective recruitment, implementation, and termination decisions so that it will be easier to evaluate to whom the results of research studies apply. Those who design clinical trials should be careful to construct them so that the clinicians who carry them out will not feel that implementing the protocol will violate their commitments to good clinical care.
临床关注和临床试验的有效性
背景:临床试验结果的有效性取决于临床研究人员和参与者始终严格遵守研究方案。然而,临床试验研究人员也被期望为参与者提供优质的医疗服务。这两项承诺在某些情况下可能会发生冲突。方法:以前用于全国互联网调查的问卷被改编为进行深入的半结构化访谈,以进一步探索报告的态度和/或行为,这些态度和/或行为表明患者的福祉有时优先于严格遵守研究方案。我们对四个主要学术医疗中心在各种医学领域从事II期和/或III期临床试验的研究人员进行了96次访谈。结果:出于对患者福利的考虑,我们采访的研究人员描述了涉及“个性化”的决定,而不是关于招募、协议实施和终止的协议驱动的决定。个性化的决定可能会威胁到试验的有效性。结论:应强烈鼓励临床研究人员仔细记录和报告选择性招募、实施和终止决定,以便更容易评估研究结果适用于谁。那些设计临床试验的人应该小心地构建它们,以便进行试验的临床医生不会觉得实施方案会违反他们对良好临床护理的承诺。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信